Decibel Therapeutics, Inc. DBTX
Set alert
4.91 +4.91 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 123.37M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -1.72
- Beta
- -0.15
- Short ratio
- 4.96
- Inst. own
- 70.72%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 8, 2023
- 50-d avg
- 3.93
- 200-d avg
- 3.40
- 1y target
- 14.40
Analyst view
Consensus: buy
Buy
Price target (mean) 14.40 +193.3% upside
Now 4.91
- Target (low)
- 2.00
- Target (mean)
- 14.40
- Target (high)
- 23.00
Recommendation trend
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.50 | -0.77 – -0.28 | -0.68 | +26.5% | 4.79M | 0.0% | 5 |
| Next quarter | -0.59 | -0.78 – -0.28 | -0.64 | +7.8% | 2.19M | 0.0% | 5 |
| Current year | -2.14 | -2.79 – -1.12 | -2.52 | +15.1% | 11.35M | 0.0% | 5 |
| Next year | -1.87 | -2.69 – -0.77 | -2.14 | +12.6% | 5.00M | -55.9% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 6, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 15, 2023 | SVB Leerink | Downgrade | Outperform | Market Perform |
| Mar 15, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 13, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jan 23, 2023 | SVB Leerink | Maintained | — | Outperform |
| Nov 10, 2022 | Citigroup | Maintained | — | Buy |
| May 17, 2022 | Citigroup | Maintained | — | Buy |
| Mar 21, 2022 | Barclays | Maintained | — | Overweight |
| Dec 2, 2021 | JonesTrading | Initiated | — | Buy |
| Nov 15, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Nov 10, 2021 | SVB Leerink | Maintained | — | Outperform |
| Oct 22, 2021 | Baird | Initiated | — | Outperform |
| May 14, 2021 | SVB Leerink | Maintained | — | Outperform |
| Mar 9, 2021 | Citigroup | Initiated | — | Buy |
| Mar 9, 2021 | BMO Capital | Initiated | — | Outperform |
| Mar 9, 2021 | Barclays | Initiated | — | Overweight |
| Mar 9, 2021 | SVB Leerink | Initiated | — | Outperform |